| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:5000 |
| IHC | 1:50-1:200 |
| IF | 1:50-1:200 |
| FC | 1:50-1:200 |
BAG1, or Bcl-2-associated athanogene 1, functions as a multifunctional regulator that bridges molecular chaperone activity with apoptotic signaling pathways. This co-chaperone interacts with heat shock proteins and modulates the anti-apoptotic function of Bcl-2, positioning it as a significant target in cancer biology and cellular stress response research. BAG1 also associates with nuclear hormone receptors, including the glucocorticoid receptor, expanding its relevance to studies of hormone signaling and transcriptional regulation.
This recombinant monoclonal antibody, clone 16C12, offers the reproducibility that demanding experimental workflows require. Generated through recombinant technology with a defined sequence, it eliminates the lot-to-lot variability inherent to traditional hybridoma-derived antibodies, ensuring consistent results across extended studies and multi-site collaborations.
Validation across multiple platforms demonstrates genuine experimental flexibility. Western blot analysis in HeLa and THP-1 whole cell lysates reveals bands at approximately 35 and 46 kDa, which differ from the predicted 39 kDa molecular weight. This pattern likely reflects the known isoforms of BAG1 generated through alternative translation initiation, as well as potential post-translational modifications. Immunohistochemistry performed on paraffin-embedded human colorectal cancer tissue shows clear target detection, while immunofluorescence staining in HeLa cells confirms utility for subcellular localization studies. Flow cytometry validation, also conducted in HeLa cells, demonstrates suitability for quantitative single-cell analysis.
Supplied in a glycerol-containing buffer optimized for long-term stability, this antibody supports researchers investigating apoptosis regulation, chaperone biology, and cancer-related pathways where BAG1 expression or localization may influence disease progression or therapeutic response.
Email: support@cusabio.com
Distributors Worldwide